TY - JOUR
AU - Cortese, Samuele
AU - Coghill, David
AU - Santosh, Paramala
AU - Hollis, Chris
AU - Simonoff, Emily
PY - 2020
DA - June
TI - Starting ADHD medications during the COVID-19 pandemic: recommendations from the European ADHD Guidelines Group
JO - The Lancet Child & Adolescent Health 
EP - E15
VL - 4
IS - 6
DO - https://doi.org/10.1016/S2352-4642(20)30144-9
AB - This addendum to our previous comment provides additional guidance from the European ADHD Guidelines Group (EAGG) on starting attention-deficit hyperactivity disorder (ADHD) medications (specifically psychostimulants and atomoxetine), during the coronavirus disease 2019 (COVID-19) pandemic, for patients who did not have a baseline, face-toface cardiovascular assessment before the crisis began.
PB - Elsevier
UR - https://discovery.dundee.ac.uk/en/publications/42dc3caa-3472-409c-bb40-ffa413cf77d9
KW - Coronavirus (COVID-19)
ER